2-157543002-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_145259.3(ACVR1C):c.944-140C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.785 in 781,776 control chromosomes in the GnomAD database, including 244,801 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.72 ( 40374 hom., cov: 31)
Exomes 𝑓: 0.80 ( 204427 hom. )
Consequence
ACVR1C
NM_145259.3 intron
NM_145259.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0670
Genes affected
ACVR1C (HGNC:18123): (activin A receptor type 1C) ACVR1C is a type I receptor for the TGFB (see MIM 190180) family of signaling molecules. Upon ligand binding, type I receptors phosphorylate cytoplasmic SMAD transcription factors, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors (Bondestam et al., 2001 [PubMed 12063393]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 2-157543002-G-T is Benign according to our data. Variant chr2-157543002-G-T is described in ClinVar as [Benign]. Clinvar id is 1252696.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACVR1C | NM_145259.3 | c.944-140C>A | intron_variant | Intron 5 of 8 | ENST00000243349.13 | NP_660302.2 | ||
ACVR1C | NM_001111031.2 | c.794-140C>A | intron_variant | Intron 5 of 8 | NP_001104501.1 | |||
ACVR1C | NM_001111032.2 | c.704-140C>A | intron_variant | Intron 4 of 7 | NP_001104502.1 | |||
ACVR1C | NM_001111033.2 | c.473-140C>A | intron_variant | Intron 3 of 6 | NP_001104503.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACVR1C | ENST00000243349.13 | c.944-140C>A | intron_variant | Intron 5 of 8 | 1 | NM_145259.3 | ENSP00000243349.7 | |||
ACVR1C | ENST00000409680.7 | c.794-140C>A | intron_variant | Intron 5 of 8 | 1 | ENSP00000387168.3 | ||||
ACVR1C | ENST00000335450.7 | c.704-140C>A | intron_variant | Intron 4 of 7 | 1 | ENSP00000335178.7 | ||||
ACVR1C | ENST00000348328.9 | c.473-140C>A | intron_variant | Intron 3 of 6 | 1 | ENSP00000335139.6 |
Frequencies
GnomAD3 genomes AF: 0.716 AC: 108458AN: 151406Hom.: 40369 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
108458
AN:
151406
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.802 AC: 505555AN: 630252Hom.: 204427 AF XY: 0.800 AC XY: 261517AN XY: 326708 show subpopulations
GnomAD4 exome
AF:
AC:
505555
AN:
630252
Hom.:
AF XY:
AC XY:
261517
AN XY:
326708
Gnomad4 AFR exome
AF:
AC:
7411
AN:
15310
Gnomad4 AMR exome
AF:
AC:
14894
AN:
19190
Gnomad4 ASJ exome
AF:
AC:
11406
AN:
14744
Gnomad4 EAS exome
AF:
AC:
29936
AN:
32046
Gnomad4 SAS exome
AF:
AC:
37172
AN:
49784
Gnomad4 FIN exome
AF:
AC:
26368
AN:
32200
Gnomad4 NFE exome
AF:
AC:
351398
AN:
432842
Gnomad4 Remaining exome
AF:
AC:
25160
AN:
31834
Heterozygous variant carriers
0
4556
9113
13669
18226
22782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
4904
9808
14712
19616
24520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.716 AC: 108484AN: 151524Hom.: 40374 Cov.: 31 AF XY: 0.720 AC XY: 53283AN XY: 74038 show subpopulations
GnomAD4 genome
AF:
AC:
108484
AN:
151524
Hom.:
Cov.:
31
AF XY:
AC XY:
53283
AN XY:
74038
Gnomad4 AFR
AF:
AC:
0.490717
AN:
0.490717
Gnomad4 AMR
AF:
AC:
0.762108
AN:
0.762108
Gnomad4 ASJ
AF:
AC:
0.764587
AN:
0.764587
Gnomad4 EAS
AF:
AC:
0.920796
AN:
0.920796
Gnomad4 SAS
AF:
AC:
0.757897
AN:
0.757897
Gnomad4 FIN
AF:
AC:
0.819643
AN:
0.819643
Gnomad4 NFE
AF:
AC:
0.804292
AN:
0.804292
Gnomad4 OTH
AF:
AC:
0.745972
AN:
0.745972
Heterozygous variant carriers
0
1411
2821
4232
5642
7053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2901
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at